BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11964040)

  • 1. Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity.
    Mori K; Chano T; Kushima R; Hukuda S; Okabe H
    Virchows Arch; 2002 Feb; 440(2):123-127. PubMed ID: 11964040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.
    Rosenberg AE; Brown GA; Bhan AK; Lee JM
    Am J Clin Pathol; 1994 Jan; 101(1):36-41. PubMed ID: 7506477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
    Huse JT; Pasha TL; Zhang PJ
    Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondroid chordoma of the sacrococcygeal region.
    Chu TA
    Arch Pathol Lab Med; 1987 Sep; 111(9):861-4. PubMed ID: 2443106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cell adhesion molecules in chordomas: an immunohistochemical study of 16 cases.
    Horiguchi H; Sano T; Qian ZR; Hirokawa M; Kagawa N; Yamaguchi T; Hirose T; Nagahiro S
    Acta Neuropathol; 2004 Feb; 107(2):91-6. PubMed ID: 14608467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
    Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
    Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
    Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chordoma. An immunohistochemical study of 20 cases.
    Meis JM; Giraldo AA
    Arch Pathol Lab Med; 1988 May; 112(5):553-6. PubMed ID: 2451900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroid chordoma. A hyalinized chordoma without cartilaginous differentiation.
    Jeffrey PB; Biava CG; Davis RL
    Am J Clin Pathol; 1995 Mar; 103(3):271-9. PubMed ID: 7532910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications.
    Hruban RH; Traganos F; Reuter VE; Huvos AG
    Am J Pathol; 1990 Aug; 137(2):435-47. PubMed ID: 1696786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroid chordoma: fine-needle aspiration cytology with histopathological, immunohistochemical, and ultrastructural study of two cases.
    Moriki T; Takahashi T; Wada M; Ueda S; Ichien M; Miyazaki E
    Diagn Cytopathol; 1999 Nov; 21(5):335-9. PubMed ID: 10527481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinicopathological and immunohistochemical study of 34 cases of chordoma].
    Hu Y; Gao Y; Zhang X
    Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):142-4. PubMed ID: 9275666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of MIB-1, E-cadherin, and CD44 in pediatric chordomas.
    Saad AG; Collins MH
    Pediatr Dev Pathol; 2005; 8(3):362-8. PubMed ID: 16010499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma.
    Naka T; Oda Y; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
    J Clin Pathol; 2001 Dec; 54(12):945-50. PubMed ID: 11729215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.
    Gottschalk D; Fehn M; Patt S; Saeger W; Kirchner T; Aigner T
    Am J Pathol; 2001 May; 158(5):1571-8. PubMed ID: 11337353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherins and catenins in clival chordomas: correlation of expression with tumor aggressiveness.
    Triana A; Sen C; Wolfe D; Hazan R
    Am J Surg Pathol; 2005 Nov; 29(11):1422-34. PubMed ID: 16224208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.
    Sommer J; Itani DM; Homlar KC; Keedy VL; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Kelley MJ; Cates JM
    J Pathol; 2010 Apr; 220(5):608-17. PubMed ID: 20140939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical and chondroid chordoma. A light-microscopic, histochemical, ultrastructural and immunohistochemical analysis of the various cell types.
    Persson S; Kindblom LG; Angervall L
    Pathol Res Pract; 1991 Sep; 187(7):828-38. PubMed ID: 1754509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.